Pfizer Fined For Hiking Epilepsy Drug Price 2,600-Percent In UKBritish regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record $112.7 million Wednesday for increasing the cost of an epilepsy drug by as much as 2,600 percent.
Bristol-Myers Drug Fails Lung Cancer Study, Shares PlungeA blockbuster cancer treatment failed in a key study as the drug's maker, Bristol-Myers Squibb, attempts to extend its usage to lung cancer patients.
Alzheimer's Drug Fails Study But Flashes Potential An Alzheimer's treatment from Eli Lilly and Co. failed to slow memory decline in two separate patient studies, but the drug did show some potential to help in mild cases of the mind-robbing condition that is notoriously difficult to treat.
Miracle Diet Pill? A Safe Drug Is ElusiveThe battle of the bulge has been a big, fat failure for U.S. drugmakers. But that hasn't stopped them from trying.